Article
The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review
15 Nov 2017
Abstract excerpt
Myelodysplastic syndromes (MDSs) are a heterogeneous group of hematopoietic stem cell diseases categorized by dysplasia in one or more hematopoietic cell lineages, as well as cytopenia and functional abnormalities in bone marrow cells. Several MDS classification methods have been proposed to categorize the disease and help professionals better plan in patients' treatment. The World Health Organization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
